Why is Boston Bio falling/rising?

As of 24-Jul, Boston Bio Systems Ltd is experiencing a decline in its stock price, currently at Rs 6.84, which reflects a decrease of Rs 0.13 or 1.87%. The stock has been underperforming, having fallen consecutively for the last four days, resulting in a total decline of 5.91% during this period. It is also trading below all its moving averages, indicating a bearish trend. Additionally, the stock is currently 4.53% away from its 52-week low of Rs 6.53. The delivery volume has significantly decreased, with a drop of 88.25% compared to the 5-day average, suggesting a lack of investor interest. There are no positive factors available to counterbalance these negative indicators.
In the broader market context, Boston Bio's performance over the past week shows a decline of 5.79%, while the Sensex has remained relatively stable with a minor decrease of only 0.09%. Over the past month, Boston Bio has seen a substantial drop of 17.39%, contrasting sharply with the Sensex's slight gain of 0.16%. This significant underperformance relative to the benchmark highlights the stock's struggles in the current market environment, further exacerbated by falling investor participation and liquidity issues.